Denmark, Novo Nordisk and Nokia
Novo Nordisk’s $570 billion valuation is more than Denmark’s GDP—but PM isn’t worried about a ‘Nokia risk’
But Danish prime minister Mette Frederiksen isn't worried about a 'Nokia risk' from pharma giant.
Novo Nordisk is bigger than Denmark's economy — but the prime minister isn't worried about another Nokia
Denmark Prime Minister Mette Frederiksen downplayed concerns that Ozempic maker Novo Nordisk (NVO), the Scandinavian nation’s largest corporation, could someday drag down its economy the way the once-dominant Nokia (NOK) did to Finland in the 2000s.
Denmark’s PM Downplays Concerns Over Novo Nordisk’s Dominance Amid Economic Growth Surge
Denmarks Prime Minister, Mette Frederiksen, rejected concerns over the economic risks posed by Novo Nordisks rapid growth. Despite comparisons to Finlands past dependence on Nokia, Frederiksen highlighted Denmarks
Danish PM Says Not Worried About Big Firms Like Novo Nordisk
Danish Prime Minister Mette Frederiksen says that she is "not really worried" about the size of firms like Novo Nordisk. "I don't see a lot of risks with the, even the size of some of the companies, because we have a very strong economy also in other sectors,
Denmark’s Premier Brushes Off Risk as Novo Outgrows Economy
Danish Prime Minister Mette Frederiksen said she’s “extremely proud” of the country’s corporate champions, and rejected concerns that any downturn at pharma giant Novo Nordisk A/S would destabilize the economy.
Evotec and Novo Nordisk in technology development partnership
German drug and development company Evotec has entered into a technology development partnership with Novo Nordisk to support ...
RFK Jr. bashes Ozempic buzz and Novo Nordisk profits
Robert F. Kennedy Jr. criticized Ozempic and Danish pharmaceutical company Novo Nordisk, arguing that fixing the food supply must be the solution to the obesity epidemic ...
Novo Nordisk CEO blames PBMs, insurers for Ozempic price tag
Senate HELP Chairman Bernie Sanders launches another salvo in drug pricing war, this one aimed at popular weight loss drugs.
Novo Nordisk Stock Slips as CEO Faces Senate Inquiry Into Wegovy, Ozempic Prices
Key Takeaways Novo Nordisk CEO Lars Fruergaard Jorgensen will testify Tuesday before a Senate panel looking into the drug ...
Why does Ozempic cost so much? Senators grilled Novo Nordisk CEO for answers.
Novo Nordisk CEO grilled over company's pricing for the diabetes drug Ozempic and the weight-loss drug Wegovy.
Novo Nordisk CEO spars with lawmakers over Ozempic, Wegovy prices
The CEO of Novo Nordisk faced pointed questions about the cost of Ozempic and Wegovy on Capitol Hill Tuesday, as lawmakers ...
Sanders, Novo Nordisk CEO clash over Ozempic, Wegovy drug prices
The CEO of Novo Nordisk wouldn’t commit to lowering the prices of Ozempic and Wegovy during a Senate hearing Tuesday, despite ...
Novo Nordisk's Options: A Look at What the Big Money is Thinking
Looking at options history for Novo Nordisk NVO we detected 11 trades. If we consider the specifics of each trade, it is ...